UnitedHealth Group Incorporated (NYSE:UNH) Director Michele J. Hooper sold 5,000 shares of UnitedHealth Group stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $222.20, for a total transaction of $1,111,000.00. Following the sale, the director now directly owns 36,989 shares in the company, valued at approximately $8,218,955.80. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Shares of UnitedHealth Group Incorporated (UNH) traded down $0.15 during mid-day trading on Wednesday, hitting $219.94. 2,397,446 shares of the stock were exchanged, compared to its average volume of 3,116,121. UnitedHealth Group Incorporated has a 52-week low of $156.09 and a 52-week high of $231.77. The company has a market capitalization of $214,570.92, a price-to-earnings ratio of 23.07, a PEG ratio of 1.64 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same period in the previous year, the business posted $2.17 earnings per share. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. sell-side analysts forecast that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be paid a $0.75 dividend. The ex-dividend date is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.36%. UnitedHealth Group’s dividend payout ratio is presently 33.26%.

A number of research analysts recently issued reports on UNH shares. Cowen reissued an “outperform” rating and set a $220.00 price target (up from $175.00) on shares of UnitedHealth Group in a research report on Friday, August 11th. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a research report on Thursday, August 17th. Jefferies Group reissued a “buy” rating and set a $215.00 price target on shares of UnitedHealth Group in a research report on Friday, August 18th. UBS reissued an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Finally, Cantor Fitzgerald reissued a “buy” rating on shares of UnitedHealth Group in a research report on Tuesday, August 29th. Three investment analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $224.56.

Several hedge funds have recently made changes to their positions in the company. Marshall Wace LLP grew its position in UnitedHealth Group by 441.4% during the second quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock valued at $2,578,000 after buying an additional 11,361 shares during the period. American Century Companies Inc. boosted its position in shares of UnitedHealth Group by 16.9% in the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after purchasing an additional 681,111 shares during the period. Schwab Charles Investment Management Inc. boosted its position in shares of UnitedHealth Group by 5.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock worth $678,077,000 after purchasing an additional 183,401 shares during the period. Essex Financial Services Inc. boosted its position in shares of UnitedHealth Group by 12.3% in the second quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock worth $1,640,000 after purchasing an additional 967 shares during the period. Finally, Factory Mutual Insurance Co. boosted its position in shares of UnitedHealth Group by 20.9% in the second quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock worth $77,245,000 after purchasing an additional 72,000 shares during the period. Hedge funds and other institutional investors own 86.20% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/12/06/unitedhealth-group-incorporated-unh-director-sells-1111000-00-in-stock.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.